Vanguard World Fund · net assets $19B · 407 holdings as of May 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.8% · STIV: 0.2% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $47.8M | $76.9M | $82.9M |
| Reinvestment | $7.28M | $0 | $0 |
| Redemptions | $153M | $147M | $102M |
| Net realized gain (non-derivative) | $51.8M | $66.3M | $30.5M |
| Net unrealized appreciation (non-derivative) | $-1.59B | $-85.1M | $434M |
The three months of the reporting period, as filed; month 3 ends May 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co EC | $2.67B | 14.04% |
| Johnson & Johnson EC | $1.61B | 8.47% |
| Abbvie Inc EC | $1.16B | 6.09% |
| Unitedhealth Group Inc EC | $1.03B | 5.45% |
| Merck & Co Inc EC | $885M | 4.66% |
| Thermo Fisher Scientific Inc EC | $556M | 2.93% |
| Amgen Inc EC | $545M | 2.87% |
| Gilead Sciences Inc EC | $501M | 2.64% |
| Intuitive Surgical Inc EC | $452M | 2.38% |
| Pfizer Inc EC | $447M | 2.35% |
| Abbott Laboratories EC | $447M | 2.35% |
| Bristol-myers Squibb Co EC | $350M | 1.84% |
| Danaher Corp EC | $349M | 1.84% |
| Cvs Health Corp EC | $347M | 1.83% |
| Vertex Pharmaceuticals Inc EC | $341M | 1.80% |
| Stryker Corp EC | $315M | 1.66% |
| Medtronic PLC EC | $284M | 1.50% |
| Mckesson Corp EC | $275M | 1.45% |
| Elevance Health Inc EC | $257M | 1.35% |
| Cigna Group/the EC | $223M | 1.17% |
| Boston Scientific Corp EC | $215M | 1.13% |
| Regeneron Pharmaceuticals Inc EC | $191M | 1.00% |
| Hca Healthcare Inc EC | $182M | 0.96% |
| Edwards Lifesciences Corp EC | $151M | 0.79% |
| Cencora Inc EC | $149M | 0.79% |
| Cardinal Health Inc EC | $140M | 0.74% |
| Idexx Laboratories Inc EC | $135M | 0.71% |
| Becton Dickinson & Co EC | $126M | 0.66% |
| Alnylam Pharmaceuticals Inc EC | $120M | 0.63% |
| Agilent Technologies Inc EC | $115M | 0.61% |
| Waters Corp EC | $113M | 0.60% |
| Humana Inc EC | $110M | 0.58% |
| Zoetis Inc EC | $103M | 0.54% |
| Iqvia Holdings Inc EC | $93.2M | 0.49% |
| Natera Inc EC | $88.2M | 0.46% |
| Centene Corp EC | $88M | 0.46% |
| Dexcom Inc EC | $86.4M | 0.46% |
| Biogen Inc EC | $86.4M | 0.45% |
| Ge Healthcare Technologies Inc EC | $85.3M | 0.45% |
| Resmed Inc EC | $83.5M | 0.44% |
| Veeva Systems Inc EC | $81.8M | 0.43% |
| Revolution Medicines Inc EC | $76.5M | 0.40% |
| Illumina Inc EC | $74.8M | 0.39% |
| Mettler-toledo International Inc EC | $72.4M | 0.38% |
| West Pharmaceutical Services Inc EC | $69.8M | 0.37% |
| Insmed Inc EC | $68.5M | 0.36% |
| United Therapeutics Corp EC | $68.4M | 0.36% |
| Quest Diagnostics Inc EC | $65.1M | 0.34% |
| Labcorp Holdings Inc EC | $64.8M | 0.34% |
| Steris PLC EC | $62.7M | 0.33% |
| Viatris Inc EC | $56.2M | 0.30% |
| Zimmer Biomet Holdings Inc EC | $49M | 0.26% |
| Incyte Corp EC | $48.5M | 0.26% |
| Neurocrine Biosciences Inc EC | $47.4M | 0.25% |
| Tenet Healthcare Corp EC | $46.3M | 0.24% |
| Guardant Health Inc EC | $43.7M | 0.23% |
| Moderna Inc EC | $43M | 0.23% |
| Jazz Pharmaceuticals PLC EC | $38.8M | 0.20% |
| Exelixis Inc EC | $38.6M | 0.20% |
| Cooper Cos Inc/the EC | $36M | 0.19% |
Showing top 60 of 407 holdings.
Loading...
